Article
Liver Steatosis-Related Polygenic Risk Score Predicts Hepatocellular Carcinoma Risk After Hepatitis C Virus Eradication.
Alimentary pharmacology & therapeutics - 1 May 2026
Lin Yu-Sheng, Lin Ying-Cheng, Chen Yun-Yu, Chen Yi-Ming, Chen I-Chieh, Tsai Hsin-Ju, Chen Chia-Chang, Lee Shou-Wu, Yang Hwai-I, Lee Teng-Yu
Abstract excerpt
BACKGROUND AND AIMS: Genetic predisposition to hepatic steatosis may increase hepatocellular carcinoma (HCC) risk after hepatitis C virus (HCV) eradication in cirrhotic patients; however, its impact on broader patient populations remains unexplored. We aimed to evaluate the association of steatosis-polygenic risk score (PRS) with HCC following direct-acting antiviral (DAA) therapy. METHODS: This retrospective...
Topics
- Humans
- Carcinoma, Hepatocellular
- Female
- Male
- Liver Neoplasms
- Retrospective Studies
- Genetic Risk Score
- Antiviral Agents
- Middle Aged
- Aged
- Taiwan
